As of 2025-10-27, the EV/EBITDA ratio of Xphyto Therapeutics Corp (XPHY.CN) is -9.31. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. XPHY.CN's latest enterprise value is 54.15 mil CAD. XPHY.CN's TTM EBITDA according to its financial statements is -5.82 mil CAD. Dividing these 2 quantities gives us the above XPHY.CN EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 0.4x - 1.6x | 1.0x |
| Forward P/E multiples | 0.6x - 2.4x | 1.5x |
| Fair Price | (0.08) - (0.14) | (0.11) |
| Upside | -115.6% - -127.3% | -123.2% |
| Date | EV/EBITDA |